Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries

We are analyzing https://link.springer.com/article/10.1007/s12026-009-8143-4.

Title:
Recovery from viral encephalomyelitis: immune-mediated noncytolytic virus clearance from neurons | Immunologic Research
Description:
Viral encephalomyelitis is caused by virus infections of neurons in the brain and spinal cord. Recovery is dependent on immune-mediated control and clearance of virus from these terminally differentiated essential cells. Preservation of neuronal function is essential for prevention of neurologic sequelae such as paralysis, seizures and cognitive deficits. Using the model system of Sindbis virus-induced encephalomyelitis in mice, we have shown that immune-mediated clearance of infectious virus from neurons is a noncytolytic process. The major effectors are antibody to the E2 surface glycoprotein produced by B cells, and interferon-Ξ³ produced by T cells. These effectors work in synergy, but neuronal populations differ in their responses to each. Virus is least likely to be cleared from brain neurons and most likely to be cleared from motor neurons in the cervical and thoracic regions of the spinal cord. Because the infected neurons are not eliminated, viral RNA persists and long-term control is needed to prevent virus reactivation. Virus-specific antibody-secreting cells residing in the nervous system after recovery from infection are likely to be important for long-term control.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {πŸ“š}

  • Science
  • Education
  • Technology & Computing

Content Management System {πŸ“}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {πŸ“ˆ}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {πŸ’Έ}

We're unsure if the website is profiting.

Earning money isn't the goal of every website; some are designed to offer support or promote social causes. People have different reasons for creating websites. This might be one such reason. Link.springer.com could be secretly minting cash, but we can't detect the process.

Keywords {πŸ”}

google, scholar, pubmed, cas, article, virus, griffin, virol, sindbis, viral, cells, mice, infection, encephalitis, immunol, neurons, system, nervous, alphavirus, central, expression, clearance, cell, replication, gene, brain, antiviral, immune, usa, role, levine, recovery, noncytolytic, neuronal, antibody, sci, interferon, stat, research, encephalomyelitis, control, strauss, med, proc, natl, acad, acute, privacy, cookies, content,

Topics {βœ’οΈ}

month download article/chapter ifn-gamma-inducible gbp2 gene ifn-alpha/beta-induced genes anti-e2 monoclonal antibody t-cell-mediated mechanisms intraparenchymal antibody-secreting cells related subjects emerging mosquito-borne zoonosis heavy-chain constant domain interferon-Ξ³ produced foxp3-expressing regulatory cd4pos rebeca burdeinick-kerr pkr/rnase l-dependent sindbis virus-infected cells interferon-gamma synergistically inhibit interferon-inducible protective gene immune-mediated clearance sindbis virus-induced encephalomyelitis jak-stat signaling pathway neuronal populations differ brain-derived gangliosides regulate central nervous system full article pdf interferon-gamma-dependent phosphorylation antibody-mediated clearance innate immune facet alternative antiviral pathways immune-mediated control alphavirus-induced apoptosis cellular immune reactivity privacy choices/manage cookies antibody-mediated downregulation acute viral encephalitis interferon-stimulated genes acute alphavirus encephalitis irani dn critical antiviral molecule ifn-alpha/beta ifngamma-mediated signaling interferon-stimulated gene 15 lethal alphavirus encephalitis check access instant access eastern equine encephalitis human arthritic disease neuroadapted sindbis virus sense viral dsrna nonstructural protein nsp2 block viral dna interferon-alpha/beta

Schema {πŸ—ΊοΈ}

WebPage:
      mainEntity:
         headline:Recovery from viral encephalomyelitis: immune-mediated noncytolytic virus clearance from neurons
         description:Viral encephalomyelitis is caused by virus infections of neurons in the brain and spinal cord. Recovery is dependent on immune-mediated control and clearance of virus from these terminally differentiated essential cells. Preservation of neuronal function is essential for prevention of neurologic sequelae such as paralysis, seizures and cognitive deficits. Using the model system of Sindbis virus-induced encephalomyelitis in mice, we have shown that immune-mediated clearance of infectious virus from neurons is a noncytolytic process. The major effectors are antibody to the E2 surface glycoprotein produced by B cells, and interferon-Ξ³ produced by T cells. These effectors work in synergy, but neuronal populations differ in their responses to each. Virus is least likely to be cleared from brain neurons and most likely to be cleared from motor neurons in the cervical and thoracic regions of the spinal cord. Because the infected neurons are not eliminated, viral RNA persists and long-term control is needed to prevent virus reactivation. Virus-specific antibody-secreting cells residing in the nervous system after recovery from infection are likely to be important for long-term control.
         datePublished:2010-01-20T00:00:00Z
         dateModified:2010-01-20T00:00:00Z
         pageStart:123
         pageEnd:133
         sameAs:https://doi.org/10.1007/s12026-009-8143-4
         keywords:
            Noncytolytic virus clearance
            Interferon-Ξ³
            Antiviral antibody
            Neuronal virus infection
            Alphavirus encephalitis
            Immunology
            Allergology
            Medicine/Public Health
            general
            Internal Medicine
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12026-009-8143-4/MediaObjects/12026_2009_8143_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12026-009-8143-4/MediaObjects/12026_2009_8143_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12026-009-8143-4/MediaObjects/12026_2009_8143_Fig3_HTML.gif
         isPartOf:
            name:Immunologic Research
            issn:
               1559-0755
               0257-277X
            volumeNumber:47
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Humana Press Inc
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Diane E. Griffin
               affiliation:
                     name:Johns Hopkins Bloomberg School of Public Health
                     address:
                        name:W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, MD, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Recovery from viral encephalomyelitis: immune-mediated noncytolytic virus clearance from neurons
      description:Viral encephalomyelitis is caused by virus infections of neurons in the brain and spinal cord. Recovery is dependent on immune-mediated control and clearance of virus from these terminally differentiated essential cells. Preservation of neuronal function is essential for prevention of neurologic sequelae such as paralysis, seizures and cognitive deficits. Using the model system of Sindbis virus-induced encephalomyelitis in mice, we have shown that immune-mediated clearance of infectious virus from neurons is a noncytolytic process. The major effectors are antibody to the E2 surface glycoprotein produced by B cells, and interferon-Ξ³ produced by T cells. These effectors work in synergy, but neuronal populations differ in their responses to each. Virus is least likely to be cleared from brain neurons and most likely to be cleared from motor neurons in the cervical and thoracic regions of the spinal cord. Because the infected neurons are not eliminated, viral RNA persists and long-term control is needed to prevent virus reactivation. Virus-specific antibody-secreting cells residing in the nervous system after recovery from infection are likely to be important for long-term control.
      datePublished:2010-01-20T00:00:00Z
      dateModified:2010-01-20T00:00:00Z
      pageStart:123
      pageEnd:133
      sameAs:https://doi.org/10.1007/s12026-009-8143-4
      keywords:
         Noncytolytic virus clearance
         Interferon-Ξ³
         Antiviral antibody
         Neuronal virus infection
         Alphavirus encephalitis
         Immunology
         Allergology
         Medicine/Public Health
         general
         Internal Medicine
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12026-009-8143-4/MediaObjects/12026_2009_8143_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12026-009-8143-4/MediaObjects/12026_2009_8143_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12026-009-8143-4/MediaObjects/12026_2009_8143_Fig3_HTML.gif
      isPartOf:
         name:Immunologic Research
         issn:
            1559-0755
            0257-277X
         volumeNumber:47
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Humana Press Inc
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Diane E. Griffin
            affiliation:
                  name:Johns Hopkins Bloomberg School of Public Health
                  address:
                     name:W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, MD, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Immunologic Research
      issn:
         1559-0755
         0257-277X
      volumeNumber:47
Organization:
      name:Humana Press Inc
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Johns Hopkins Bloomberg School of Public Health
      address:
         name:W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, MD, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Diane E. Griffin
      affiliation:
            name:Johns Hopkins Bloomberg School of Public Health
            address:
               name:W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, MD, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, MD, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {πŸ”—}(246)

Analytics and Tracking {πŸ“Š}

  • Google Tag Manager

Libraries {πŸ“š}

  • Clipboard.js
  • Prism.js

4.27s.